Emergex Provides an Update on First-in-Human Studies of Its Novel Dengue Fever and...

cafead

Administrator
Staff member
  • cafead   Apr 18, 2022 at 11:22: AM
via
  • Both studies fully recruited, with data from the Dengue Fever study anticipated in the summer
  • Preclinical data for Emergex’s Coronavirus vaccine candidate suggests that it could provide heterologous immunity to viruses from the same family

article source
 

<